Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
580K
-
Shares change
-
+264K
-
Total reported value, excl. options
-
$3.75M
-
Value change
-
+$1.71M
-
Number of buys
-
11
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2023
12 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2023.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 580K shares
of 71.9M outstanding shares and own 0.81% of the company stock.
Largest 10 shareholders include Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.4K shares), UBS Group AG (9.1K shares), MORGAN STANLEY (4.57K shares), JPMORGAN CHASE & CO (3K shares), WELLS FARGO & COMPANY/MN (1.66K shares), and GROUP ONE TRADING, L.P. (412 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.